English

Raptor Pharmaceutical Corp

EDGAR

RPTP Quarterly report (10-Q) · filed 2016-08-04

91 filing records in this dataset, filed from 1999-06-30 to 2016-08-04. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

32 million USD

2016 Q2 · USD

Exact inputs and evidence

Revenue: 32045000 USD Source

Operating margin

-29.5%

2016 Q2 · %

Exact inputs and evidence

Operating Income: -9452000 USD Source
Revenue: 32045000 USD Source

Operating cash flow

-5.13 million USD

2016 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -27051000 USD Source
Operating Cash Flow: -21925000 USD Source

Free cash flow

-5.4 million USD

2016 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -27051000 USD Source
Operating Cash Flow: -21925000 USD Source
Capital Expenditure: 581000 USD Source
Capital Expenditure: 307000 USD Source

Cash and cash equivalents: 124 million USD 2016-06-30 Source
Exact value

124239000 USD
Long-term debt including current maturities: 45 million USD 2016-06-30 Source
Exact value

45000000 USD
Shares outstanding: 85.5 million shares 2016-06-30 Source
Exact value

85531006 shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-08-04.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2015-12-31
Operating income: 7 of 11 periods available· newest 2015-12-31
Net income: 7 of 11 periods available· newest 2015-12-31
Operating cash flow: 7 of 11 periods available· newest 2015-12-31
Capital expenditure: 7 of 11 periods available· newest 2015-12-31
Total assets: 8 of 11 periods available· newest 2015-12-31
Total liabilities: 8 of 11 periods available· newest 2015-12-31
Current assets: 8 of 11 periods available· newest 2015-12-31
Current liabilities: 8 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2015-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2015-12-31
Shares outstanding: 3 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+35.6%

Prior period

USD 69.5 million

2014-01-01 – 2014-12-31
Current period

USD 94.24 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

94240000 − 69497000 = 24743000 USD

69497000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
94240000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Raptor Pharmaceutical Corp · 2015-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Year-over-year change in Revenue: 24743000 USD Concept: fundies:Revenue Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 94240000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#145592 Filing: 000156459016013558 Input fundies:Revenue: 69497000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#145735 Filing: 000156459016013558
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 12.68 million

Prior period

−USD 52.54 million

2014-01-01 – 2014-12-31
Current period

−USD 65.22 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-65222000 − -52540000 = -12682000 USD

-52540000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-65222000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Raptor Pharmaceutical Corp · 2015-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Year-over-year change in Net income: -12682000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -65222000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#152933 Filing: 000156459016013558 Input fundies:NetIncome: -52540000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#153087 Filing: 000156459016013558
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.82 million

Prior period

−USD 46.98 million

2014-01-01 – 2014-12-31
Current period

−USD 44.16 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-44159000 − -46981000 = 2822000 USD

-46981000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-44159000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Raptor Pharmaceutical Corp · 2015-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Year-over-year change in Operating cash flow: 2822000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -44159000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#207655 Filing: 000156459016013558 Input fundies:OperatingCashFlow: -46981000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#207907 Filing: 000156459016013558
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-43.2%

Prior period

USD 5.09 million

2014-01-01 – 2014-12-31
Current period

USD 2.89 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

2890000 − 5086000 = -2196000 USD

5086000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
2890000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Raptor Pharmaceutical Corp · 2015-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Year-over-year change in Capital expenditure: -2196000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2890000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208411 Filing: 000156459016013558 Input fundies:CapitalExpenditure: 5086000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208621 Filing: 000156459016013558
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 94.24 million 100% of revenue
Cost of revenue USD 12.62 million 13% of revenue
Operating expenses USD 130.08 million 138% of revenue
Operating income −USD 48.46 million −51% of revenue
Tax, interest and other Derived USD 16.76 million 18% of revenue
Net income −USD 65.22 million −69% of revenue

Cash

Operating cash flow −USD 44.16 million −47% of revenue
Capital expenditure USD 2.89 million 3.1% of revenue
Free cash flow Derived −USD 47.05 million −50% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Operating loss: operating costs were 250% of revenue.
2006 Operating loss: operating costs were 352% of revenue.
2007 Operating loss: operating costs were 341% of revenue.
2008 Operating loss: operating costs were 458% of revenue.
2013 Operating loss: operating costs were 408% of revenue.
2014 Operating loss: operating costs were 158% of revenue.
2015 Operating loss: operating costs were 151% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2005-01-01 – 2005-12-31	7967000	19905000 Derived	-11938000	-396000 Derived	-11542000	-1613000 Derived	Source 2005-01-01 – 2005-12-31: 7967000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -11938000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -11542000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -911000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 702000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	9850000	34652000 Derived	-24802000	575000 Derived	-25377000	-26981000 Derived	Source 2006-01-01 – 2006-12-31: 9850000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -24802000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -25377000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -26847000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 134000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	9850000	33620000 Derived	-23770000	-401000 Derived	-23369000	-20045000 Derived	Source 2007-01-01 – 2007-12-31: 9850000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -23770000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -23369000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -19694000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 351000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	6071000	27824000 Derived	-21753000	1032000 Derived	-22785000	-20923000 Derived	Source 2008-01-01 – 2008-12-31: 6071000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -21753000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -22785000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -20904000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 19000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	16872000	68778000 Derived	-51906000	17511000 Derived	-69417000	-48182000 Derived	Source 2013-01-01 – 2013-12-31: 16872000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -51906000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -69417000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -46596000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 1586000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	69497000	109547000 Derived	-40050000	12490000 Derived	-52540000	-52067000 Derived	Source 2014-01-01 – 2014-12-31: 69497000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -40050000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -52540000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -46981000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 5086000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	94240000	142698000 Derived	-48458000	16764000 Derived	-65222000	-47049000 Derived	Source 2015-01-01 – 2015-12-31: 94240000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -48458000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -65222000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -44159000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 2890000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 94.2M 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Revenue	7967000	Revenue: 7967000 Open source
20062006-12-31	Revenue	9850000	Revenue: 9850000 Open source
20072007-12-31	Revenue	9850000	Revenue: 9850000 Open source
20082008-12-31	Revenue	6071000	Revenue: 6071000 Open source
20132013-12-31	Revenue	16872000	Revenue: 16872000 Open source
20142014-12-31	Revenue	69497000	Revenue: 69497000 Open source
20152015-12-31	Revenue	94240000	Revenue: 94240000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

35.6% 2015

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Year over year	No prior comparable period	Revenue: 7967000 Open source
20062006-12-31	Year over year	23.6%	Revenue: 9850000 Open source Revenue: 7967000 Open source
20072007-12-31	Year over year	0%	Revenue: 9850000 Open source Revenue: 9850000 Open source
20082008-12-31	Year over year	-38.4%	Revenue: 6071000 Open source Revenue: 9850000 Open source
20132013-12-31	Year over year	No prior comparable period	Revenue: 16872000 Open source
20142014-12-31	Year over year	311.9%	Revenue: 69497000 Open source Revenue: 16872000 Open source
20152015-12-31	Year over year	35.6%	Revenue: 94240000 Open source Revenue: 69497000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -51.4% 2015

Net margin -69.2% 2015

Free cash flow margin -49.9% 2015

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Operating margin	-149.8%	Operating Income: -11938000 Open source Revenue: 7967000 Open source
20062006-12-31	Operating margin	-251.8%	Operating Income: -24802000 Open source Revenue: 9850000 Open source
20072007-12-31	Operating margin	-241.3%	Operating Income: -23770000 Open source Revenue: 9850000 Open source
20082008-12-31	Operating margin	-358.3%	Operating Income: -21753000 Open source Revenue: 6071000 Open source
20132013-12-31	Operating margin	-307.6%	Operating Income: -51906000 Open source Revenue: 16872000 Open source
20142014-12-31	Operating margin	-57.6%	Operating Income: -40050000 Open source Revenue: 69497000 Open source
20152015-12-31	Operating margin	-51.4%	Operating Income: -48458000 Open source Revenue: 94240000 Open source
20052005-12-31	Net margin	-144.9%	Net Income: -11542000 Open source Revenue: 7967000 Open source
20062006-12-31	Net margin	-257.6%	Net Income: -25377000 Open source Revenue: 9850000 Open source
20072007-12-31	Net margin	-237.2%	Net Income: -23369000 Open source Revenue: 9850000 Open source
20082008-12-31	Net margin	-375.3%	Net Income: -22785000 Open source Revenue: 6071000 Open source
20132013-12-31	Net margin	-411.4%	Net Income: -69417000 Open source Revenue: 16872000 Open source
20142014-12-31	Net margin	-75.6%	Net Income: -52540000 Open source Revenue: 69497000 Open source
20152015-12-31	Net margin	-69.2%	Net Income: -65222000 Open source Revenue: 94240000 Open source
20052005-12-31	Free cash flow margin	-20.2%	Revenue: 7967000 Open source Operating Cash Flow: -911000 Open source Capital Expenditure: 702000 Open source
20062006-12-31	Free cash flow margin	-273.9%	Revenue: 9850000 Open source Operating Cash Flow: -26847000 Open source Capital Expenditure: 134000 Open source
20072007-12-31	Free cash flow margin	-203.5%	Revenue: 9850000 Open source Operating Cash Flow: -19694000 Open source Capital Expenditure: 351000 Open source
20082008-12-31	Free cash flow margin	-344.6%	Revenue: 6071000 Open source Operating Cash Flow: -20904000 Open source Capital Expenditure: 19000 Open source
20132013-12-31	Free cash flow margin	-285.6%	Revenue: 16872000 Open source Operating Cash Flow: -46596000 Open source Capital Expenditure: 1586000 Open source
20142014-12-31	Free cash flow margin	-74.9%	Revenue: 69497000 Open source Operating Cash Flow: -46981000 Open source Capital Expenditure: 5086000 Open source
20152015-12-31	Free cash flow margin	-49.9%	Revenue: 94240000 Open source Operating Cash Flow: -44159000 Open source Capital Expenditure: 2890000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -44.2M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Operating cash flow	-911000	Operating Cash Flow: -911000 Open source
20062006-12-31	Operating cash flow	-26847000	Operating Cash Flow: -26847000 Open source
20072007-12-31	Operating cash flow	-19694000	Operating Cash Flow: -19694000 Open source
20082008-12-31	Operating cash flow	-20904000	Operating Cash Flow: -20904000 Open source
20132013-12-31	Operating cash flow	-46596000	Operating Cash Flow: -46596000 Open source
20142014-12-31	Operating cash flow	-46981000	Operating Cash Flow: -46981000 Open source
20152015-12-31	Operating cash flow	-44159000	Operating Cash Flow: -44159000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -47M 2015

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Free cash flow	-1613000	Operating Cash Flow: -911000 Open source Capital Expenditure: 702000 Open source
20062006-12-31	Free cash flow	-26981000	Operating Cash Flow: -26847000 Open source Capital Expenditure: 134000 Open source
20072007-12-31	Free cash flow	-20045000	Operating Cash Flow: -19694000 Open source Capital Expenditure: 351000 Open source
20082008-12-31	Free cash flow	-20923000	Operating Cash Flow: -20904000 Open source Capital Expenditure: 19000 Open source
20132013-12-31	Free cash flow	-48182000	Operating Cash Flow: -46596000 Open source Capital Expenditure: 1586000 Open source
20142014-12-31	Free cash flow	-52067000	Operating Cash Flow: -46981000 Open source Capital Expenditure: 5086000 Open source
20152015-12-31	Free cash flow	-47049000	Operating Cash Flow: -44159000 Open source Capital Expenditure: 2890000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

72.1% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Liabilities / assets	18.2%	Total Liabilities: 5659000 Open source Total Assets: 31103735 Open source
20062006-12-31	Liabilities / assets	29.7%	Total Liabilities: 18866000 Open source Total Assets: 63435000 Open source
20072007-12-31	Liabilities / assets	31.5%	Total Liabilities: 12192000 Open source Total Assets: 38652000 Open source
20082008-12-31	Liabilities / assets	66.6%	Total Liabilities: 7417000 Open source Total Assets: 11130000 Open source
2013-12-31	Liabilities / assets	Not reported	No source recorded
20142014-12-31	Liabilities / assets	74.1%	Total Liabilities: 140120000 Open source Total Assets: 189066000 Open source
20152015-12-31	Liabilities / assets	72.1%	Total Liabilities: 302298000 Open source Total Assets: 419490000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.6× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Current assets / current liabilities	6.37×	Current Assets: 29423626 Open source Current Liabilities: 4617489 Open source
20062006-12-31	Current assets / current liabilities	4.56×	Current Assets: 55964000 Open source Current Liabilities: 12270000 Open source
20072007-12-31	Current assets / current liabilities	3.69×	Current Assets: 33335000 Open source Current Liabilities: 9036000 Open source
20082008-12-31	Current assets / current liabilities	2.08×	Current Assets: 11051000 Open source Current Liabilities: 5305000 Open source
2013-12-31	Current assets / current liabilities	Not reported	No source recorded
20142014-12-31	Current assets / current liabilities	5.89×	Current Assets: 171605000 Open source Current Liabilities: 29120000 Open source
20152015-12-31	Current assets / current liabilities	4.6×	Current Assets: 181399000 Open source Current Liabilities: 39455000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	−USD 11.54 million Exact value Exact value: -11542000 USD 2005-01-01 – 2005-12-31: -11542000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Raptor Pharmaceutical Corp · 2005-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Net Income: -11542000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11542000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001047469-08-003801.txt#7140 The citation records this snapshot. The page link may show a newer release later.	−USD 911,000 Exact value Exact value: -911000 USD 2005-01-01 – 2005-12-31: -911000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Raptor Pharmaceutical Corp · 2005-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Operating Cash Flow: -911000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -911000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001047469-08-003801.txt#7389 The citation records this snapshot. The page link may show a newer release later.	USD 702,000 Exact value Exact value: 702000 USD 2005-01-01 – 2005-12-31: 702000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Raptor Pharmaceutical Corp · 2005-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Capital Expenditure: 702000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 702000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001047469-08-003801.txt#7454 The citation records this snapshot. The page link may show a newer release later.	−USD 1.61 million Calculation and evidence -911000 − 702000 USD Exact free cash flow: -1613000 USD 2005-01-01 – 2005-12-31: -911000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 702000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Raptor Pharmaceutical Corp · 2005-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Free cash flow: -1613000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -911000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001047469-08-003801.txt#7389 Input fundies:CapitalExpenditure: 702000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001047469-08-003801.txt#7454 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 25.38 million Exact value Exact value: -25377000 USD 2006-01-01 – 2006-12-31: -25377000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Raptor Pharmaceutical Corp · 2006-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Net Income: -25377000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25377000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9054 The citation records this snapshot. The page link may show a newer release later.	−USD 26.85 million Exact value Exact value: -26847000 USD 2006-01-01 – 2006-12-31: -26847000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Raptor Pharmaceutical Corp · 2006-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Operating Cash Flow: -26847000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26847000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9390 The citation records this snapshot. The page link may show a newer release later.	USD 134,000 Exact value Exact value: 134000 USD 2006-01-01 – 2006-12-31: 134000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Raptor Pharmaceutical Corp · 2006-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Capital Expenditure: 134000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 134000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9488 The citation records this snapshot. The page link may show a newer release later.	−USD 26.98 million Calculation and evidence -26847000 − 134000 USD Exact free cash flow: -26981000 USD 2006-01-01 – 2006-12-31: -26847000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 134000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Raptor Pharmaceutical Corp · 2006-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Free cash flow: -26981000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26847000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9390 Input fundies:CapitalExpenditure: 134000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9488 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 23.37 million Exact value Exact value: -23369000 USD 2007-01-01 – 2007-12-31: -23369000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Raptor Pharmaceutical Corp · 2007-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Net Income: -23369000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23369000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9054 The citation records this snapshot. The page link may show a newer release later.	−USD 19.69 million Exact value Exact value: -19694000 USD 2007-01-01 – 2007-12-31: -19694000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Raptor Pharmaceutical Corp · 2007-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Operating Cash Flow: -19694000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19694000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9390 The citation records this snapshot. The page link may show a newer release later.	USD 351,000 Exact value Exact value: 351000 USD 2007-01-01 – 2007-12-31: 351000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Raptor Pharmaceutical Corp · 2007-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Capital Expenditure: 351000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 351000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9488 The citation records this snapshot. The page link may show a newer release later.	−USD 20.05 million Calculation and evidence -19694000 − 351000 USD Exact free cash flow: -20045000 USD 2007-01-01 – 2007-12-31: -19694000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 351000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Raptor Pharmaceutical Corp · 2007-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Free cash flow: -20045000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19694000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9390 Input fundies:CapitalExpenditure: 351000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9488 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 22.79 million Exact value Exact value: -22785000 USD 2008-01-01 – 2008-12-31: -22785000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Raptor Pharmaceutical Corp · 2008-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Net Income: -22785000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22785000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9054 The citation records this snapshot. The page link may show a newer release later.	−USD 20.9 million Exact value Exact value: -20904000 USD 2008-01-01 – 2008-12-31: -20904000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Raptor Pharmaceutical Corp · 2008-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Operating Cash Flow: -20904000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20904000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9390 The citation records this snapshot. The page link may show a newer release later.	USD 19,000 Exact value Exact value: 19000 USD 2008-01-01 – 2008-12-31: 19000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Raptor Pharmaceutical Corp · 2008-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Capital Expenditure: 19000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 19000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9488 The citation records this snapshot. The page link may show a newer release later.	−USD 20.92 million Calculation and evidence -20904000 − 19000 USD Exact free cash flow: -20923000 USD 2008-01-01 – 2008-12-31: -20904000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 19000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Raptor Pharmaceutical Corp · 2008-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Free cash flow: -20923000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20904000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9390 Input fundies:CapitalExpenditure: 19000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/0001193125-09-066121.txt#9488 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 69.42 million Exact value Exact value: -69417000 USD 2013-01-01 – 2013-12-31: -69417000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Raptor Pharmaceutical Corp · 2013-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Net Income: -69417000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -69417000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#153241 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.	−USD 46.6 million Exact value Exact value: -46596000 USD 2013-01-01 – 2013-12-31: -46596000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Raptor Pharmaceutical Corp · 2013-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Operating Cash Flow: -46596000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46596000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208159 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.	USD 1.59 million Exact value Exact value: 1586000 USD 2013-01-01 – 2013-12-31: 1586000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Raptor Pharmaceutical Corp · 2013-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Capital Expenditure: 1586000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1586000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208831 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.	−USD 48.18 million Calculation and evidence -46596000 − 1586000 USD Exact free cash flow: -48182000 USD 2013-01-01 – 2013-12-31: -46596000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 1586000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Raptor Pharmaceutical Corp · 2013-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Free cash flow: -48182000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46596000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208159 Filing: 000156459016013558 Input fundies:CapitalExpenditure: 1586000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208831 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 52.54 million Exact value Exact value: -52540000 USD 2014-01-01 – 2014-12-31: -52540000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Raptor Pharmaceutical Corp · 2014-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Net Income: -52540000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -52540000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#153087 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.	−USD 46.98 million Exact value Exact value: -46981000 USD 2014-01-01 – 2014-12-31: -46981000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Raptor Pharmaceutical Corp · 2014-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Operating Cash Flow: -46981000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46981000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#207907 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.	USD 5.09 million Exact value Exact value: 5086000 USD 2014-01-01 – 2014-12-31: 5086000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Raptor Pharmaceutical Corp · 2014-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Capital Expenditure: 5086000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5086000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208621 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.	−USD 52.07 million Calculation and evidence -46981000 − 5086000 USD Exact free cash flow: -52067000 USD 2014-01-01 – 2014-12-31: -46981000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 5086000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Raptor Pharmaceutical Corp · 2014-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Free cash flow: -52067000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46981000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#207907 Filing: 000156459016013558 Input fundies:CapitalExpenditure: 5086000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208621 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 65.22 million Exact value Exact value: -65222000 USD 2015-01-01 – 2015-12-31: -65222000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Raptor Pharmaceutical Corp · 2015-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Net Income: -65222000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -65222000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#152933 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.	−USD 44.16 million Exact value Exact value: -44159000 USD 2015-01-01 – 2015-12-31: -44159000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Raptor Pharmaceutical Corp · 2015-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Operating Cash Flow: -44159000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -44159000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#207655 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.	USD 2.89 million Exact value Exact value: 2890000 USD 2015-01-01 – 2015-12-31: 2890000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Raptor Pharmaceutical Corp · 2015-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Capital Expenditure: 2890000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2890000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208411 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.	−USD 47.05 million Calculation and evidence -44159000 − 2890000 USD Exact free cash flow: -47049000 USD 2015-01-01 – 2015-12-31: -44159000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 2890000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Raptor Pharmaceutical Corp · 2015-12-31 Raptor Pharmaceutical Corp (edgar:1070698) Free cash flow: -47049000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1070698?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -44159000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#207655 Filing: 000156459016013558 Input fundies:CapitalExpenditure: 2890000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1070698/000156459016013558/rptp-20151231.xml#208411 Filing: 000156459016013558 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

91 filings · 2,245 latest values · 2,245 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001070698, 1070698, RPTP, edgar:1070698

Also known as AXONYX INC, HORIZON PHARMACEUTICAL LLC, Raptor Pharmaceutical Corp, Raptor Pharmaceutical Corp., TorreyPines Therapeutics, Inc.

Raptor Pharmaceutical Corp

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation